Cynosure Hold Exclusive Trade Pre-Launch For SculpSure

Leading laser and light-based aesthetic treatment company, Cynosure, unveiled their new FDA approved treatment, SculpSure; to customers on January 7th at Home House in London.

Doctors and practitioners were introduced to the ground breaking SculpSure technology through live demonstrations and discussions.

The guests included Dr. Tapan Patel, director of PHI Clinic – the first clinic in the UK to treat patients with the SculpSure laser. As well as Lisa Littlehouse, Managing Director of Cavendish Clinic, Dr. Nicholas Lowe, founder of Cranley Clinic, Faizeen Zavahir, Medical Director of Juvea Clinic, Lena Andersson, founder of Anelca Clinic and Dr. Beata Cybulska.

The new body-sculpting laser has been touted as a ‘game changer’ for the aesthetic market, offering convenient, comfortable, non-invasive fat reduction for any body and skin type. Cynosure spokesperson Bill Kelley, said: “SculpSure is a revolutionary, highly advanced procedure, is a clever combination of the science of laser technology with the art of body contouring”.

Cynosure UK Cynosure is a leading developer and manufacturer of a broad array of lightbased aesthetic and medical treatment systems. Cynosure’s products are used to provide a diverse range of treatment applications such as hair removal, skin revitalisation and scar reduction, as well as tattoo removal and the treatment of vascular lesions.

SculpSure will officially launch to consumers in March 2016.